首页> 外文会议>Biomedical Engineering and Biotechnology (iCBEB), 2012 International Conference on >Synthesis, Characterization and Antitumor Activity of Rare Earth Eu3+ and Dy3+ Complexes with Quercetin
【24h】

Synthesis, Characterization and Antitumor Activity of Rare Earth Eu3+ and Dy3+ Complexes with Quercetin

机译:槲皮素稀土Eu3 +和Dy3 +配合物的合成,表征和抗肿瘤活性

获取原文

摘要

The complexes of rare earth element Eu3+ and Dy3+ with quercetin were synthesized and characterized by elemental analysis, molar conductance, FTIR and UV-Vis spectra. The antitumor activities of the ligand and complexes were assayed against human hepatocarcinoma cell line HepG2 by MTT colorimetric assay. The results indicate that the formulas of the compounds are EuC15H8O7Cl10•6H2O and DyC15H8O7Cl2•6H2O. MTT assay showed that Quercetin, Eu3+-quercetin and Dy3+-quercetin dose dependently inhibited the proliferation of HepG2 cells, and the proliferation inhibition rates of cell treated with rare earth ion complexes of quercetin were significantly higher than those treated with quercetin. The antitumor activities of the complexes are markedly stronger than that of the ligand.
机译:合成了稀土元素Eu3 +和Dy3 +与槲皮素的配合物,并通过元素分析,摩尔电导,FTIR和UV-Vis光谱进行了表征。通过MTT比色测定法测定了该配体和复合物的抗肿瘤活性对人肝癌细胞HepG2的活性。结果表明,该化合物的分子式为EuC15H8O7Cl10·6H2O和DyC15H8O7Cl2·6H2O。 MTT法测定槲皮素,Eu3 +-槲皮素和Dy3 +-槲皮素剂量依赖性地抑制HepG2细胞的增殖,槲皮素稀土离子复合物处理的细胞的增殖抑制率明显高于槲皮素。复合物的抗肿瘤活性明显强于配体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号